This session reviews the outcomes data and risk/benefit profile of anticoagulant/antithrombotic medications to help hospice staff and clinicians make informed, data-driven decisions about continuing or deprescribing these medications in hospice and palliative care.

Learning Objectives:

• Discuss indications for various antithrombotic medications.
• Understand the annualized VTE and stroke risk of various conditions based on clinical research.
• Understand the data on bleeding risk for hospice/palliative care patients.
• List several validated tools for estimating VTE and stroke and bleeding risk.
• Discuss a rational decision-making process for antithrombotic use in hospice/palliative care.